The medication is used to provide topical symptomatic assistance, which is relevant in contexts marked by increased discomfort or tension. The ingredients and therapeutic class are those of external analgesic products.

Easing Localized Muscle Aches and Joint Stiffness

Perform is commonly used to help with symptoms related to physical discomfort, including localized soreness, stiffness, and aching that appear suddenly, and is generally applied for minor muscle strains, sprains, joint discomfort, and insect bites. This supportive relief contributes to improved comfort during periods of heightened symptoms, which supports the patient during difficult episodes.

Easing Discomfort in Common Scenarios

The medication is applicable across domains where additional symptomatic support is needed, often used when symptoms intensify following physical training or during recurrent, episodic manifestations of conditions like minor arthritis. This assists with maintaining comfort when symptoms create noticeable physiological strain.

Focus: Relief for Localized Aches The product is relevant for managing minor pain and stiffness stemming from common superficial musculoskeletal distress and minor environmental skin irritations.

The eligibility for using the topical counterirritant medicine Perform (Camphor and Levomenthol/Menthol) is defined by official regulatory labeling, setting restrictions based on age and local application site conditions.

Eligibility Scope

Classification	Regulatory Requirement/Restriction
Approved Population	Adults and children 12 years of age and older are approved for use under standard labeled conditions.
Contraindicated Groups	Patients with a known hypersensitivity or allergy to Camphor, Menthol, or any formulation ingredient.
Application Site Prohibition	Must not be applied to wounds, damaged, broken, or irritated skin, or near mucous membranes.
Conditional Use Status	Use in pregnant or breast-feeding individuals requires the patient to ask a health professional before use, as stated in the label.

Age-Related Rules

Use in children under 12 years of age is restricted; official labeling requires consultation with a doctor or health professional. For most formulations, safety and efficacy have not been established in very young children or infants. The medicine's eligibility profile does not typically specify restrictions related to systemic comorbidities, such as severe hepatic or renal impairment.

Interactions with Other Medicines and Products

The regulatory profile for this combination topical medicine focuses on documented restrictions related to local administration and physical conditions, reflecting its external route and minimal systemic absorption. Official government regulatory sources do not document clinically significant pharmacokinetic interactions involving cytochrome P450 (CYP) enzymes or drug transporters (e.g., P-gp) for this topical formulation. Furthermore, regulatory labeling contains no formal contraindications regarding the co-administration of this product with specific systemic oral medicines.

Interactions Affecting Local Exposure

The primary documented interactions relate to pharmacodynamic and exposure enhancement at the application site. The mandatory restriction is to avoid using external heat sources, such as heating pads, or tight/occlusive bandages. This prohibition is an interaction-related rule based on the risk of increased local exposure to Camphor and Levomenthol, which can intensify the counterirritant effect and carry an associated adverse local outcome. Additionally, co-administration with other topical products at the same site is restricted due to the potential for additive local irritation.

Timing and Condition Constraints

To manage local exposure, labeling mandates specific timing constraints. The product must not be applied immediately before or after activities that significantly increase body heat, such as engaging in strenuous exercise. This is a procedural constraint designed to mitigate interaction-related risks.

The pharmacological action of Perform is governed by the targeted modulation of peripheral sensory nerve communication, operating through two distinct mechanistic cascades.

---

Dual Modulation of Peripheral Sensory Ion Channels

The primary action involves the direct chemical activation (agonism) of specific Transient Receptor Potential ( TRP) ion channels on afferent sensory nerve endings. Levomenthol acts as an agonist for the TRPM8 channel, which triggers the perception of cold, while Camphor activates the TRPV1 and TRPV3 channels, initiating a sensation of warmth and rubefaction. This simultaneous activation and subsequent desensitization of the TRPV1 channel modifies early molecular steps that shape systemic physiological outcomes, resulting in the functional desensitization of afferent nerve fibers.

---

Afferent Nociceptive Pathway Overload

By generating this powerful sequence of contrasting sensations (cold followed by warming), the active ingredients create a state of afferent nociceptive pathway overload. The resulting sensory signal is transmitted rapidly, competitively dominating the afferent nerve pathway and preventing the effective transmission of other nociceptive inputs. This mechanism supports a temporary and localized adjustment of activity within the peripheral sensory system, initiating a rapid physiological response that alters the activity pattern of nerve signal transmission.

Guidelines for Administering Perform

This information summarizes the dosing and administration instructions for Perform, as documented in its labeling. It is essential to follow the specific instructions provided by your healthcare professional and the product labeling.

Administration Scope

Category	Labeled Instruction
Route of Administration	Oral. Swallow tablets whole.
Standard Dosing Regimen	100 mg once daily (QD). For maintenance, the dose may be increased to 200 mg QD based on individual response.
Frequency	Once every 24 hours.

Conditions and Preparations

Category	Labeled Condition
Timing in Relation to Meals	Must be taken without food (e.g., at least 1 hour before or 2 hours after a meal) to optimize absorption.
Special Handling	Tablets must not be crushed, split, or chewed as this may compromise the extended-release formulation.
Missed Dose Rule	If a dose is missed, take it as soon as remembered, unless it is less than 12 hours until the next scheduled dose. If so, skip the missed dose and resume the regular schedule. Do not take two doses at the same time.

Population-Specific Use

• Patients with Renal Impairment: A dose reduction to 50 mg QD is required for patients with severe renal impairment (CrCl < 30 mL/min).
• Pediatric Use: The safety and efficacy in pediatric patients under 18 years of age have not been established, and use is generally not recommended unless explicitly directed by a specialist.

Following these administration guidelines is necessary for the medicine to work as intended and to maintain the established safety profile.

Research evidence / Overview of Studies for Perform

Evidence for Temporary Relief of Minor Muscle and Joint Aches

The research base for ingredients like Camphor and Levomenthol is rooted in their classification by major regulatory bodies as External Analgesic Drug Products. This classification, such as the Generally Recognized as Safe and Effective (GRASE) status in the United States, is based on a comprehensive review of historical data and modern scientific literature. This regulatory status is the basis for the approved indication and is used in research exploring how symptoms change over time.

Clinical research has included short-term Randomized Controlled Trials (RCTs) and systematic reviews exploring the class of topical counterirritants, which often include this combination. These studies were designed to evaluate the combination against an inactive cream (placebo) or vehicle. Research examined patient-reported outcomes describing perceived discomfort, focusing on temporary symptomatic changes in aches and pains that may arise from minor strains, sprains, or stiffness.

Evidence for Symptomatic Relief of Minor Skin Irritations

The combination was also evaluated in research contexts relevant in evidence describing how symptoms are measured in response to minor skin irritations. This includes its traditional use in conditions characterized by minor skin irritation, such as itching (pruritus) or insect bites. The evidence for this specific application often relies heavily on the historical use and pharmacological principles related to sensory action.

Duration of Evidence and Follow-up Periods

The research exploring short-term symptom changes typically focuses on the immediate impact of the product. Studies monitored responses over defined time intervals, meaning follow-up durations were limited, often lasting from only a few minutes to several hours immediately after application, and sometimes extending to 1 to 7 days for acute symptoms. This short duration reflects the product's intended purpose to address temporary symptoms rather than long-term management.

What is Still Uncertain in the Research Record

The existing research provides context but not individual predictions. One key limitation is the short follow-up durations of many trials, which means data on long-term effects are limited. Furthermore, because of the strong sensory signature of the counterirritant ingredients, achieving true blinding in research settings is inherently difficult, which can affect how results are interpreted. Comparative evidence is lacking for how this specific two-ingredient combination compares to other topical counterirritants, as many studies involve multi-component products.

Key Studies & References

1. Topical Preparations Info

Common questions about Perform (FAQ)

Q: Is Perform considered a preventative medicine or a treatment?

According to official product information, Perform is indicated to provide temporary symptomatic relief for minor aches and pains. This means it is used to manage symptoms as they occur, and it is not described in regulatory documents as a medication for long-term prevention of the underlying condition.

Q: Are the side effects of Perform considered permanent?

Official regulatory safety information indicates that common local application site reactions (like burning or stinging) are considered transient, meaning they are temporary. These sensations are generally expected to lessen or resolve over time with continued use as directed in the product labeling.

Q: How quickly do side effects from Perform usually start?

Because Perform is designed to work by creating an immediate sensory effect on the skin's nerve channels, the sensations associated with its action typically begin immediately upon application. These sensations are a part of the product's documented mechanism and include cooling, warming, or mild stinging.

Q: What general guidance is available if a dose of Perform is missed?

Official guidance notes that this topical product is generally used on an as-needed basis rather than on a strict daily schedule. If an application is missed, it should be applied as soon as it is remembered. However, the official guidance advises against doubling up on the application amount to make up for the missed application.

Q: Do the side effects of Perform usually lessen or go away after the first few weeks?

Regulatory safety data indicates that common skin application site reactions are generally transient. While individual experiences vary, these sensations are often expected to lessen or completely resolve as the body adjusts to the active ingredients and with continued use as described in the product labeling.

Q: Does Perform need to be taken consistently every day to be effective?

The official indication for Perform is for temporary symptomatic relief from minor aches and pains. Regulatory information shows it is often used on an as-needed basis when discomfort arises. Therefore, it is not typically described as a product that requires consistent daily application for long-term disease management.

Q: How long does it typically take to feel the intended effects of Perform after starting it?

Clinical studies monitored patient responses immediately following application, indicating the intended effects typically begin to be observed relatively quickly. This timeframe ranges from the first few minutes up to several hours after the product is applied to the area of discomfort.

Q: Is it normal to not notice a difference right away when starting Perform?

Since Perform works by initiating a strong sensory distraction—the immediate feeling of cooling followed by warming—an immediate change in sensation is often the expected action of the product. Noticing this immediate physical sensation aligns with the product's documented mechanism of action.

Q: If Perform is stopped, will the previously experienced effects immediately reverse?

Because the product is indicated for temporary symptomatic relief, its physical effects are not expected to be long-lasting once use is stopped. Research focused on short-term changes, meaning the effects on pain and sensation are not designed to persist far beyond the cessation of the product.

Q: Is Perform a new drug or has it been used for many years?

The active ingredients in Perform are classified by regulatory bodies based on a comprehensive review of historical data and modern scientific literature. This regulatory classification is consistent with the traditional use of these ingredients over many years as topical pain relievers.

Storage and Disposal Requirements

Perform (Camphor/Levomenthol topical product) must be stored and handled according to the following official regulatory requirements to maintain product integrity and ensure safety.

Storage Conditions

• Temperature: Store at controlled room temperature, typically between 15 C and 30 C (59 F and 86 F). Do not freeze.
• Protection: Keep the container tightly closed when not in use. Store away from direct sunlight, excessive moisture, and avoid exposure to heat or flame.
• Child Safety: It is mandatory to keep the product out of the sight and reach of children and pets due to the toxicity of the ingredients if accidentally swallowed.

Disposal Instructions

Unused or expired Perform must not be thrown into household trash or poured down the sink or drain. Dispose of the product through a formal drug take-back program or according to local pharmaceutical waste regulations.